New publication about the treatment of focal-onset seizures (FOS) in patients with drug resistant epilepsy (DRE) in Spain
We are very pleased to share a new publication of which OMAKASE is a co-author t [...]
Revalmed Coordination Group meeting June 2021
We are glad to inform you about the Revalmed Coordination Group regular meeting [...]
Summary of P&R decisions CIPM June 2021
The June 2021 Summary of P&R decisions in Spain is now available for downloa [...]
June 2021 update of the Horizon Scanning report where Omakase Consulting is working with Orphar-SEFH
The update of the Horizon Scanning developed in collaboration with Orphar-SEFH g [...]
New publication about the treatment of triple-class refractory multiple myeloma in Spain
We are very pleased to share the latest publication for which OMAKASE is a coaut [...]
The AEMPS, recognised with the 2021 Public Health Figure award granted by Fundamed & Wecare-u
The Spanish agency of medicines, the AEMPS, has been recognised for their work t [...]
Revalmed Coordination Group meeting May 2021
We are glad to inform you about the Revalmed Coordination Group regular meeting [...]
New evidence about risk factors of infections in adults due to carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumannii in Spain
We are proud to publish with national experts in infectious diseases and microbi [...]
Updated Annual Report on Orphan Drugs authorised in Spain and approved by the European Commission between 2003 & 2020
We are proud to announce the release of the annual update of the "Report on Orph [...]
Alicia Gil, miembro de SWL
Como CEO de Omakase Consulting y profesional vinculada durante toda mi carrera a [...]